Low diurnal variability of apolipoprotein A1, apolipoprotein B and apolipoprotein B/apolipoprotein A1 ratio during normal sleep and after an acute shift of sleep

Clinical Biochemistry

Volumn 41, Issue 10-11, 2008, Pages 859-862

  Larsson, Anders ^a   Carlsson, Lena ^a   Axelsson, John ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apolipoprotein A1; Apolipoprotein B; Diurnal variation; Human

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BIOLOGICAL MARKER;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; CARDIOVASCULAR RISK; CLINICAL ARTICLE; HUMAN; MALE; NIGHT SLEEP; PRIORITY JOURNAL; SOMNOLENCE;

ADULT; ANALYSIS OF VARIANCE; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; EATING; HABITUATION, PSYCHOPHYSIOLOGIC; HUMANS; POLYSOMNOGRAPHY; REFERENCE VALUES; SLEEP; WORK SCHEDULE TOLERANCE;

EID: 44949233110     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.02.018     Document Type: Article

References (18)

1. Huxley R., Lewington S., and Clarke R. Cholesterol, coronary heart disease and stroke: a review of published evidence from observational studies and randomized controlled trials. Semin Vasc Med 2 (2002) 315-323
2. Evans M., Roberts A., Davies S., and Rees A. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Drugs 64 (2004) 1181-1196
3. Dean B.B., Borenstein J.E., Henning J.M., Knight K., and Merz C.N. Can change in high-density lipoprotein cholesterol levels reduce cardiovascular risk?. Am Heart J 147 (2004) 966-976
4. Walldius G., and Jungner I. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy-a review of the evidence. J Intern Med 259 (2006) 493-519
5. Walldius G., and Jungner I. Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy. Eur Heart J 26 (2005) 210-212
6. Jiang R., Schulze M.B., Li T., et al. Non-HDL cholesterol and apolipoprotein b predict cardiovascular disease events among men with type 2 diabetes. Diabetes Care 27 (2004) 1991-1997
7. Ridker P.M., Rifai N., Cook N.R., Bradwin G., and Buring J.E. Non-HDL cholesterol, apolipoproteins A-I and B-100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. J Am Med Assoc 294 (2005) 326-333
8. Rechtschaffen A., and Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects (1968), US Department of Health, Education and Welfare, Public Health Service, Bethesda, MD
9. Axelsson J., Ingre M., Åkerstedt T., and Holmbäck U. Effects of acutely displaced sleep on testosterone. J Clin Endocrinol Metab 90 (2005) 4530-4535
10. Nelson W., Tong Y.L., Lee J.K., and Halberg F. Methods for cosinor rhythmometry. Chronobiologia 6 (1979) 305-323
11. Huynh H., and Feldt L.S. Estimation of the Box correction for degrees of freedom from sample data in randomized block and split-plot designs. J. Educ. Behav. Stat. 1 (1976) 69-82
12. Huxley R., Lewington S., and Clarke R. Cholesterol, coronary heart disease and stroke: a review of published evidence from observational studies and randomized controlled trials. Semin Vasc Med 2 (2002) 315-323
13. Evans M., Roberts A., Davies S., and Rees A. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Drugs 64 (2004) 1181-1196
14. Dean B.B., Borenstein J.E., Henning J.M., Knight K., and Merz C.N. Can change in high-density lipoprotein cholesterol levels reduce cardiovascular risk?. Am Heart J 147 (2004) 966-976
15. Barter P.J., Ballantyne C.M., Carmena R., et al. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/tencountry panel. J Intern Med 259 (2006) 247-258
16. Nazir D.J., Roberts R.S., Hill S.A., and McQueen M.J. Monthly intra-individual variation in lipids over a 1-year period in 22 normal subjects. Clin Biochem 32 (1999) 381-389
17. Romon M., Le Fur C., Lebel P., Edmé J.L., Fruchart J.C., and Dallongeville J. Circadian variation of postprandial lipemia. Am J Clin Nutr 65 (1997) 934-940
18. Rivera-Coll A., Fuentes-Arderiu X., and Díez-Noguera A. Circadian rhythmic variations in serum concentrations of clinically important lipids. Clin Chem 40 (1994) 1549-1553